Biological Science: Research Developments and Innovations Vol. 4

Nanoparticle-based formulations have been advanced for more than a decade as instruments for reconciling agricultural productivity with reduced chemical intensity, yet the relationship between mechanistic promise and demonstrated field benefit remains contested. This critical narrative review examines the evidence for nanoparticle-enabled fertilisers, crop-protection products, stress-mitigation treatments and biomolecule carriers, and evaluates whether the sustainability claims attached to them are supported by the quality of the underlying research. Literature was identified through structured searching of multidisciplinary and life-science scholarly indexes, supplemented by citation tracking and examination of authoritative institutional guidance, with all bibliographic records and digital object identifiers verified against registry sources. Evidence was appraised for design adequacy, comparator selection, dose metrics, exposure realism and external validity, and was synthesised thematically around mechanisms, contested findings and translational constraints rather than by individual study. Four conclusions emerge. Efficacy gains relative to conventional analogues are real but modest and highly variable, and are strongest for micronutrient formulations applied to deficient or stressed systems. Macronutrient nanoformulations, particularly nano-urea, show sharply conflicting field outcomes that cannot be reconciled without attention to nitrogen rate, application timing and the choice of comparator. Environmental and soil-microbial consequences are frequently inhibitory, dose-dependent and modulated by soil properties, so the assumption that reduced application mass equates to reduced ecological burden is not generally secure. Economic and life-cycle accounting remains sparse, and the manufacturing burden of nanomaterials can offset field-level savings. The dominant constraint on the field is methodological rather than conceptual: short-duration, glasshouse-scale, hydroponic or pot studies with inappropriate controls and incomplete particle characterisation cannot support claims about agronomic sustainability. Priorities include multi-season replicated field experimentation with ionic and bulk comparators, standardised reporting of particle properties and applied dose, integration of soil-health and non-target endpoints into efficacy trials, and transparent cost and life-cycle accounting before commercial scale-up.